(RVNC)—Daewoo recently received an FDA Form-483 citation for an issue at the Korean plant where Evolus’ botulinum toxin, DWP-415 is made, according to Wells Fargo.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”